Management of anterior chamber dislocation of a dexamethasone intravitreal implant: A case report

被引:0
|
作者
Pacella F. [1 ]
Agostinelli E. [2 ]
Carlesimo S.C. [1 ]
Nebbioso M. [1 ]
Secondi R. [1 ]
Forastiere M. [1 ]
Pacella E. [1 ]
机构
[1] Department of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, Viale del Policlinico, Rome
[2] Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome
关键词
Case report; Cystoid macular edema; Intravitreal dexamethasone implant; Ozurdex; Ozurdex dislocation;
D O I
10.1186/s13256-016-1077-2
中图分类号
学科分类号
摘要
Background: Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be managed by repositioning the implant into the vitreous cavity. We describe the case of a successful repositioning of an Ozurdex implant by mobilization and subsequent balanced saline solution injection in the anterior chamber. Case presentation: An 83-year-old white woman presented to our Emergency Unit complaining of pain and vision loss in herright eye lasting a week. Her anamnesis revealed a history of persistent cystoid macular edema after phacoemulsification with scleral-fixated posterior chamber intraocular lens implantation, recently treated with an intravitreal Ozurdex implant. She also took a long-distance flight 2 days after the injection. An anterior segment examination showed corneal edema and the rod implant adherent to corneal endothelium. To avoid corneal decompensation, we opted for a implant repositioning. Under topical anesthesia, a 30-gauge needle was introduced through a limbar incisionto mobilize the dislocated rod. Balanced saline solution was injected, with a successful repositioning of the implant into the vitreous cavity. Topical 5 % hypertonic saline solution and 0.2 % betamethasone associated with 0.5 % chloramphenicol drops were administered four times a day. To prevent redislocation of the Ozurdex implant, she was instructed to avoid prone position, any kind of physical effort, and not to undertake long-distance flights during the first postoperative week. One week after surgery, an anterior segment examination showed an improvement of corneal edema. Funduscopy showed that the Ozurdex implant was settled into the vitreous cavity. Conclusions: Anterior chamber dislocation of Ozurdex from the vitreous cavity is rare. In our patient, in addition to the posterior capsule tearing, the long-distance flight could have contributed to implant dislocation. Repositioning of the implant is necessary to avoid endothelial decompensation. It can be carried out by using saline balanced solution with the same efficacy as other surgical procedures reported in the literature. A possible disadvantage of this procedure could be implant migration. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [41] Cystic roof collapse after intravitreal injection of dexamethasone implant, a case report
    Romano, Francesco
    Albertini, Giorgia Carlotta
    Arrigo, Alessandro
    Parodi, Maurizio Battaglia
    Bandello, Francesco
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (04) : NP16 - NP18
  • [42] Refractory adult Coats disease treated with dexamethasone intravitreal implant A case report
    Ding, Yu-hua
    Yao, Bang-tao
    Zhao, Xiao-gui
    Yu, Hao
    Liu, Gang
    Wang, Xiu-ying
    MEDICINE, 2020, 99 (20)
  • [43] Migration of a Dexamethasone Intravitreal Implant to the Anterior Chamber in a Patient with a Intra-Scleral Haptic Fixated Intraocular Lens
    Jamshidi, Farzad
    Shah, Vinay A.
    Riaz, Kamran M.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 633 - 635
  • [44] Intravitreal dexamethasone implant——a new treatment for idiopathic posterior scleritis: A case report
    Yong-Ji Zhao
    Yu-Ling Zou
    Ying Lu
    Meng-Jun Tu
    Zhi-Peng You
    World Journal of Clinical Cases, 2021, 9 (02) : 422 - 428
  • [45] Intravitreal dexamethasone implant - a new treatment for idiopathic posterior scleritis: A case report
    Zhao, Yong-Ji
    Zou, Yu-Ling
    Lu, Ying
    Tu, Meng-Jun
    You, Zhi-Peng
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (02) : 422 - 428
  • [46] A Report of High Intraocular Pressure With the Dexamethasone Intravitreal Implant
    Saraiya, Nehali Vira
    Patel, Sarju S.
    Goldstein, Debra A.
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (12) : 1638 - 1639
  • [47] Management of autoimmune retinopathy treated with intravitreal dexamethasone implant
    Si-Meng Hou
    Qian Liu
    Xiao-Yan Peng
    Yi-Bin Li
    Zhi-Hua Li
    Hui-Yang Zeng
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 1381 - 1389
  • [48] Management of autoimmune retinopathy treated with intravitreal dexamethasone implant
    Hou, Si-Meng
    Liu, Qian
    Peng, Xiao-Yan
    Li, Yi-Bin
    Li, Zhi-Hua
    Zeng, Hui-Yang
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (05) : 1381 - 1389
  • [49] Bilateral Spontaneous Crystalline Lens Dislocation to the Anterior Chamber: A Case Report
    Jovanovic, Milos
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (11-12) : 800 - 802
  • [50] Dislocation of the crystalline lens into the anterior chamber following couching: Case report
    Jait, A.
    Jait, M.
    Lezrek, O.
    Amazouzi, A.
    El Haouzi, S.
    Charkaoui, W.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (09): : E327 - E328